These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1059 related articles for article (PubMed ID: 33746091)

  • 41. Correlation of autopsy pathological findings and imaging features from 9 fatal cases of COVID-19 pneumonia.
    Zhao L; Wang X; Xiong Y; Fan Y; Zhou Y; Zhu W
    Medicine (Baltimore); 2021 Mar; 100(12):e25232. PubMed ID: 33761714
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma.
    Cele S; Gazy I; Jackson L; Hwa SH; Tegally H; Lustig G; Giandhari J; Pillay S; Wilkinson E; Naidoo Y; Karim F; Ganga Y; Khan K; Bernstein M; Balazs AB; Gosnell BI; Hanekom W; Moosa MS; ; ; Lessells RJ; de Oliveira T; Sigal A
    Nature; 2021 May; 593(7857):142-146. PubMed ID: 33780970
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Scandal over COVID vaccine trial at Peruvian universities prompts outrage.
    Taylor L
    Nature; 2021 Apr; 592(7853):174-175. PubMed ID: 33772240
    [No Abstract]   [Full Text] [Related]  

  • 44. What scientists do and don't know about the Oxford-AstraZeneca COVID vaccine.
    Mallapaty S; Callaway E
    Nature; 2021 Apr; 592(7852):15-17. PubMed ID: 33762708
    [No Abstract]   [Full Text] [Related]  

  • 45. Pulmonary vascular proliferation in patients with severe COVID-19: an autopsy study.
    Pérez-Mies B; Gómez-Rojo M; Carretero-Barrio I; Bardi T; Benito A; García-Cosío M; Caballero Á; de Pablo R; Galán JC; Pestaña D; Palacios J
    Thorax; 2021 Oct; 76(10):1044-1046. PubMed ID: 33758071
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fetal and placental infection with SARS-CoV-2 in early pregnancy.
    Valdespino-Vázquez MY; Helguera-Repetto CA; León-Juárez M; Villavicencio-Carrisoza O; Flores-Pliego A; Moreno-Verduzco ER; Díaz-Pérez DL; Villegas-Mota I; Carrasco-Ramírez E; López-Martínez IE; Giraldo-Gómez DM; Lira R; Yocupicio-Monroy M; Rodríguez-Bosch M; Sevilla-Reyes EE; Cortés-Bonilla M; Acevedo-Gallegos S; Merchant-Larios H; Cardona-Pérez JA; Irles C
    J Med Virol; 2021 Jul; 93(7):4480-4487. PubMed ID: 33764543
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The emerging plasticity of SARS-CoV-2.
    McCormick KD; Jacobs JL; Mellors JW
    Science; 2021 Mar; 371(6536):1306-1308. PubMed ID: 33766871
    [No Abstract]   [Full Text] [Related]  

  • 48. Detection methods for SARS-CoV-2 in tissue.
    von Stillfried S; Boor P
    Pathologe; 2021 Nov; 42(Suppl 1):81-88. PubMed ID: 33770236
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessing Asymptomatic, Presymptomatic, and Symptomatic Transmission Risk of Severe Acute Respiratory Syndrome Coronavirus 2.
    Wu P; Liu F; Chang Z; Lin Y; Ren M; Zheng C; Li Y; Peng Z; Qin Y; Yu J; Geng M; Yang X; Zhao H; Li Z; Zhou S; Ran L; Cowling BJ; Lai S; Chen Q; Wang L; Tsang TK; Li Z
    Clin Infect Dis; 2021 Sep; 73(6):e1314-e1320. PubMed ID: 33772573
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Emergence and outcomes of the SARS-CoV-2 'Marseille-4' variant.
    Fournier PE; Colson P; Levasseur A; Devaux CA; Gautret P; Bedotto M; Delerce J; Brechard L; Pinault L; Lagier JC; Fenollar F; Raoult D
    Int J Infect Dis; 2021 May; 106():228-236. PubMed ID: 33785459
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rapid Detection of SARS-CoV-2 Variants of Concern, Including B.1.1.28/P.1, British Columbia, Canada.
    Matic N; Lowe CF; Ritchie G; Stefanovic A; Lawson T; Jang W; Young M; Dong W; Brumme ZL; Brumme CJ; Leung V; Romney MG
    Emerg Infect Dis; 2021 Jun; 27(6):1673-1676. PubMed ID: 33784237
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies.
    Planas D; Bruel T; Grzelak L; Guivel-Benhassine F; Staropoli I; Porrot F; Planchais C; Buchrieser J; Rajah MM; Bishop E; Albert M; Donati F; Prot M; Behillil S; Enouf V; Maquart M; Smati-Lafarge M; Varon E; Schortgen F; Yahyaoui L; Gonzalez M; De Sèze J; Péré H; Veyer D; Sève A; Simon-Lorière E; Fafi-Kremer S; Stefic K; Mouquet H; Hocqueloux L; van der Werf S; Prazuck T; Schwartz O
    Nat Med; 2021 May; 27(5):917-924. PubMed ID: 33772244
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Convalescent plasma treatment of critically ill intensive care COVID-19 patients.
    Lindemann M; Lenz V; Knop D; Klump H; Alt M; Aufderhorst UW; Schipper L; Schwarzkopf S; Meller L; Steckel N; Koldehoff M; Heinold A; Heinemann FM; Fischer J; Hutschenreuter G; Knabbe C; Dolff S; Brenner T; Dittmer U; Witzke O; Herbstreit F; Horn PA; Krawczyk A
    Transfusion; 2021 May; 61(5):1394-1403. PubMed ID: 33784412
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications.
    Abdool Karim SS; de Oliveira T
    N Engl J Med; 2021 May; 384(19):1866-1868. PubMed ID: 33761203
    [No Abstract]   [Full Text] [Related]  

  • 55. SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies.
    Hoffmann M; Arora P; Groß R; Seidel A; Hörnich BF; Hahn AS; Krüger N; Graichen L; Hofmann-Winkler H; Kempf A; Winkler MS; Schulz S; Jäck HM; Jahrsdörfer B; Schrezenmeier H; Müller M; Kleger A; Münch J; Pöhlmann S
    Cell; 2021 Apr; 184(9):2384-2393.e12. PubMed ID: 33794143
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The spatial landscape of lung pathology during COVID-19 progression.
    Rendeiro AF; Ravichandran H; Bram Y; Chandar V; Kim J; Meydan C; Park J; Foox J; Hether T; Warren S; Kim Y; Reeves J; Salvatore S; Mason CE; Swanson EC; Borczuk AC; Elemento O; Schwartz RE
    Nature; 2021 May; 593(7860):564-569. PubMed ID: 33780969
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience.
    Bryce C; Grimes Z; Pujadas E; Ahuja S; Beasley MB; Albrecht R; Hernandez T; Stock A; Zhao Z; AlRasheed MR; Chen J; Li L; Wang D; Corben A; Haines GK; Westra WH; Umphlett M; Gordon RE; Reidy J; Petersen B; Salem F; Fiel MI; El Jamal SM; Tsankova NM; Houldsworth J; Mussa Z; Veremis B; Sordillo E; Gitman MR; Nowak M; Brody R; Harpaz N; Merad M; Gnjatic S; Liu WC; Schotsaert M; Miorin L; Aydillo Gomez TA; Ramos-Lopez I; Garcia-Sastre A; Donnelly R; Seigler P; Keys C; Cameron J; Moultrie I; Washington KL; Treatman J; Sebra R; Jhang J; Firpo A; Lednicky J; Paniz-Mondolfi A; Cordon-Cardo C; Fowkes ME
    Mod Pathol; 2021 Aug; 34(8):1456-1467. PubMed ID: 33795830
    [TBL] [Abstract][Full Text] [Related]  

  • 58. COVID-19 (SARS-CoV-2) infection and thrombotic conditions: A systematic review and meta-analysis.
    Gabbai-Armelin PR; de Oliveira AB; Ferrisse TM; Sales LS; Barbosa ERO; Miranda ML; Salomão KB; Brighenti FL
    Eur J Clin Invest; 2021 Jun; 51(6):e13559. PubMed ID: 33772772
    [TBL] [Abstract][Full Text] [Related]  

  • 59. WHO International Standard for anti-SARS-CoV-2 immunoglobulin.
    Kristiansen PA; Page M; Bernasconi V; Mattiuzzo G; Dull P; Makar K; Plotkin S; Knezevic I
    Lancet; 2021 Apr; 397(10282):1347-1348. PubMed ID: 33770519
    [No Abstract]   [Full Text] [Related]  

  • 60. Daily briefing: Coronavirus could have killed 40 million people if the world had not taken action.
    Graham F; Castelvecchi D; Mallapaty S
    Nature; 2020 Mar; ():. PubMed ID: 33782594
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.